Eculizumab 300 MG Injection: Warning and Precautions

Eculizumab (Brand Name: Soliris) 300 mg is a monoclonal antibody that binds to complement protein C5 and blocks terminal complement activation. The eculizumab injection is approved to treat patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and some forms of generalized myasthenia gravis and neuromyelitis optica spectrum disorder. In patients taking treatment with this […]

Soliris (Eculizumab Injection) Dosage, and Side Effects

Background: Soliris (Eculizumab Injection) is a medicine launched for the treatment of patients with paroxysmal nocturnal haemoglobinuria (PNH), generalised myasthaenia gravis (GMG), atypical haemolytic uraemic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD). The medication is developed and manufactured by the US based pharmaceutical company Alexion Pharmaceuticals, a subsidiary of AstraZeneca. It was given orphan […]